159 related articles for article (PubMed ID: 23546445)
1. Heart failure: Aldosterone antagonism for HFpEF.
Borlaug BA
Nat Rev Cardiol; 2013 May; 10(5):244-6. PubMed ID: 23546445
[No Abstract] [Full Text] [Related]
2. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
[TBL] [Abstract][Full Text] [Related]
3. [Spironolactone not effective in diastolic heart failure].
Voors AA
Ned Tijdschr Geneeskd; 2014; 158():A7805. PubMed ID: 25004789
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF).
Edelmann F; Schmidt AG; Gelbrich G; Binder L; Herrmann-Lingen C; Halle M; Hasenfuss G; Wachter R; Pieske B
Eur J Heart Fail; 2010 Aug; 12(8):874-82. PubMed ID: 20538867
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone inhibition in patients with heart failure with preserved ejection fraction.
Lund LH; Ståhlberg M
JAMA; 2013 Jul; 310(2):205. PubMed ID: 23839758
[No Abstract] [Full Text] [Related]
6. Aldosterone inhibition in patients with heart failure with preserved ejection fraction.
Milan A; Abram S; Veglio F
JAMA; 2013 Jul; 310(2):204-5. PubMed ID: 23839757
[No Abstract] [Full Text] [Related]
7. Aldosterone inhibition in patients with heart failure with preserved ejection fraction.
Neil CJ; Singh S; Frenneaux M
JAMA; 2013 Jul; 310(2):204. PubMed ID: 23839756
[No Abstract] [Full Text] [Related]
8. Aldosterone inhibition in patients with heart failure with preserved ejection fraction--reply.
Edelmann F; Wachter R; Pieske B
JAMA; 2013 Jul; 310(2):205-7. PubMed ID: 23839759
[No Abstract] [Full Text] [Related]
9. Blocking aldosterone in heart failure.
Shafiq MM; Miller AB
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):379-85. PubMed ID: 19661156
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.
Orea-Tejeda A; Colín-Ramírez E; Castillo-Martínez L; Asensio-Lafuente E; Corzo-León D; González-Toledo R; Rebollar-González V; Narváez-David R; Dorantes-García J
Rev Invest Clin; 2007; 59(2):103-7. PubMed ID: 17633796
[TBL] [Abstract][Full Text] [Related]
11. [Heart failure with preserved ejection fraction (diastolic heart failure)].
Güder G; Ertl G
MMW Fortschr Med; 2019 May; 161(9):58-65. PubMed ID: 31079412
[No Abstract] [Full Text] [Related]
12. Defining diastolic heart failure and identifying effective therapies.
Cleland JG; Pellicori P
JAMA; 2013 Feb; 309(8):825-6. PubMed ID: 23443447
[No Abstract] [Full Text] [Related]
13. Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction.
McDiarmid AK; Swoboda PP; Erhayiem B; Bounford KA; Bijsterveld P; Tyndall K; Fent GJ; Garg P; Dobson LE; Musa TA; Foley JRJ; Witte KK; Kearney MT; Greenwood JP; Plein S
J Am Heart Assoc; 2020 Jan; 9(1):e011521. PubMed ID: 31852424
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone antagonism and congestive heart failure: a new look at an old therapy.
Thohan V; Torre-Amione G; Koerner MM
Curr Opin Cardiol; 2004 Jul; 19(4):301-8. PubMed ID: 15218387
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
Capuano A; Scavone C; Vitale C; Sportiello L; Rossi F; Rosano GM; Coats AJ
Int J Cardiol; 2015 Dec; 200():15-9. PubMed ID: 26404747
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
[TBL] [Abstract][Full Text] [Related]
17. Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.
Gupta A; Schiros CG; Gaddam KK; Aban I; Denney TS; Lloyd SG; Oparil S; Dell'Italia LJ; Calhoun DA; Gupta H
J Hum Hypertens; 2015 Apr; 29(4):241-6. PubMed ID: 25231508
[TBL] [Abstract][Full Text] [Related]
18. Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
Kosmala W; Rojek A; Przewlocka-Kosmala M; Wright L; Mysiak A; Marwick TH
J Am Coll Cardiol; 2016 Oct; 68(17):1823-1834. PubMed ID: 27765184
[TBL] [Abstract][Full Text] [Related]
19. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?
Pitt B
J Card Fail; 2002 Dec; 8(6 Suppl):S491-3. PubMed ID: 12555163
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.
Leopold JA
Circulation; 2011 Nov; 124(18):e466-8. PubMed ID: 22042931
[No Abstract] [Full Text] [Related]
[Next] [New Search]
